zidovudine has been researched along with Growth Disorders in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Aizire, J; Atuhaire, P; Boivin, MJ; Familiar, I; Fowler, MG; Katumbi, C; Maliwichi, L; Mutebe, A; Ogwang, LW; Sikorskii, A; Taha, T | 1 |
De Bruyn, G; Gray, GE; Harwell, JI; Lurie, MN; McGarvey, ST; Triche, EW; Venkatesh, KK | 1 |
Dabis, F; Elenga, N; Fassinou, P; Msellati, P; Viho, I | 1 |
Bryson, YJ; Geffner, ME; Israele, V; Landaw, EM; Scott, ML; Stiehm, ER; Yeh, DY | 1 |
Caballero, B; Henderson, RA; Hutton, N; Talusan, K; Yolken, RH | 1 |
1 trial(s) available for zidovudine and Growth Disorders
Article | Year |
---|---|
Growth of infants born to HIV-infected women in South Africa according to maternal and infant characteristics.
Topics: Adult; Anti-HIV Agents; Body Height; Body Weight; CD4 Lymphocyte Count; Epidemiologic Methods; Female; Growth Disorders; HIV Infections; Humans; Infant Formula; Infant Nutritional Physiological Phenomena; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Maternal Age; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Viral Load; Young Adult; Zidovudine | 2010 |
4 other study(ies) available for zidovudine and Growth Disorders
Article | Year |
---|---|
Growth deficits in antiretroviral and HIV-exposed uninfected versus unexposed children in Malawi and Uganda persist through 60 months of age.
Topics: Child; Female; Follow-Up Studies; Growth Disorders; HIV Infections; Humans; Infant; Longitudinal Studies; Malawi; Uganda; Zidovudine | 2022 |
[Zidovudine-associated mitochondriopathy: three possible observations in Abidjan, Côte d'Ivoire].
Topics: Adult; Anemia, Hypochromic; Anti-HIV Agents; Cohort Studies; Comorbidity; Cote d'Ivoire; Epilepsy, Generalized; Failure to Thrive; Female; Fetus; Growth Disorders; HIV Infections; Humans; Infant; Male; Mitochondria; Muscle Hypotonia; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Protein-Energy Malnutrition; Psychomotor Disorders; Randomized Controlled Trials as Topic; Zidovudine | 2004 |
In vitro insulin-like growth factor-I, growth hormone, and insulin resistance occurs in symptomatic human immunodeficiency virus-1-infected children.
Topics: Child; Child, Preschool; Erythropoiesis; Female; Growth Disorders; Growth Hormone; HIV Infections; HIV-1; Humans; In Vitro Techniques; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Male; Zidovudine | 1993 |
Resting energy expenditure and body composition in children with HIV infection.
Topics: Adipose Tissue; Anthropometry; Anti-HIV Agents; Arm; Body Composition; Body Water; Child; Child Development; Child, Preschool; Didanosine; Energy Intake; Energy Metabolism; Female; Growth Disorders; HIV Infections; Humans; Male; Muscle Development; Muscle, Skeletal; Skinfold Thickness; Zidovudine | 1998 |